517 related articles for article (PubMed ID: 25845813)
1. Differentiation of solitary brain metastasis from glioblastoma multiforme: a predictive multiparametric approach using combined MR diffusion and perfusion.
Bauer AH; Erly W; Moser FG; Maya M; Nael K
Neuroradiology; 2015 Jul; 57(7):697-703. PubMed ID: 25845813
[TBL] [Abstract][Full Text] [Related]
2. Differentiation of glioblastoma multiforme, metastases and primary central nervous system lymphomas using multiparametric perfusion and diffusion MR imaging of a tumor core and a peritumoral zone-Searching for a practical approach.
Neska-Matuszewska M; Bladowska J; Sąsiadek M; Zimny A
PLoS One; 2018; 13(1):e0191341. PubMed ID: 29342201
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of brain infection from necrotic glioblastoma using combined analysis of diffusion and perfusion MRI.
Chawla S; Wang S; Mohan S; Nasrallah M; Verma G; Brem S; O'Rourke DM; Wolf RL; Poptani H; Nabavizadeh SA
J Magn Reson Imaging; 2019 Jan; 49(1):184-194. PubMed ID: 29676844
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of glioblastoma multiforme from metastatic brain tumor using proton magnetic resonance spectroscopy, diffusion and perfusion metrics at 3 T.
Tsougos I; Svolos P; Kousi E; Fountas K; Theodorou K; Fezoulidis I; Kapsalaki E
Cancer Imaging; 2012 Oct; 12(3):423-36. PubMed ID: 23108208
[TBL] [Abstract][Full Text] [Related]
5. Differentiation of Glioblastoma and Solitary Brain Metastasis by Gradient of Relative Cerebral Blood Volume in the Peritumoral Brain Zone Derived from Dynamic Susceptibility Contrast Perfusion Magnetic Resonance Imaging.
She D; Xing Z; Cao D
J Comput Assist Tomogr; 2019; 43(1):13-17. PubMed ID: 30015801
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic examination performance by using microvascular leakage, cerebral blood volume, and blood flow derived from 3-T dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in the differentiation of glioblastoma multiforme and brain metastasis.
Server A; Orheim TE; Graff BA; Josefsen R; Kumar T; Nakstad PH
Neuroradiology; 2011 May; 53(5):319-30. PubMed ID: 20625709
[TBL] [Abstract][Full Text] [Related]
7. Discriminating glioblastoma from solitary brain metastases on 3 Tesla magnetic resonance imaging: the roles of fractional anisotropy and mean diffusivity.
Nguyen DH; Le TD; Nguyen HV; Nguyen-Thi VA; Nguyen DH; Dong-Van H; Nguyen MD
Eur Rev Med Pharmacol Sci; 2022 Dec; 26(23):8823-8831. PubMed ID: 36524501
[TBL] [Abstract][Full Text] [Related]
8. Glioblastoma multiforme versus solitary supratentorial brain metastasis: differentiation based on morphology and magnetic resonance signal characteristics.
Maurer MH; Synowitz M; Badakshi H; Lohkamp LN; Wüstefeld J; Schäfer ML; Wiener E
Rofo; 2013 Mar; 185(3):235-40. PubMed ID: 23196836
[TBL] [Abstract][Full Text] [Related]
9. Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors.
Calli C; Kitis O; Yunten N; Yurtseven T; Islekel S; Akalin T
Eur J Radiol; 2006 Jun; 58(3):394-403. PubMed ID: 16527438
[TBL] [Abstract][Full Text] [Related]
10. Multiparametric MRI for Differentiation of Radiation Necrosis From Recurrent Tumor in Patients With Treated Glioblastoma.
Nael K; Bauer AH; Hormigo A; Lemole M; Germano IM; Puig J; Stea B
AJR Am J Roentgenol; 2018 Jan; 210(1):18-23. PubMed ID: 28952810
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of peritumoral minimum apparent diffusion coefficient for differentiation of glioblastoma multiforme from solitary metastatic lesions.
Lee EJ; terBrugge K; Mikulis D; Choi DS; Bae JM; Lee SK; Moon SY
AJR Am J Roentgenol; 2011 Jan; 196(1):71-6. PubMed ID: 21178049
[TBL] [Abstract][Full Text] [Related]
12. Which combination of MR imaging modalities is best for predicting recurrent glioblastoma? Study of diagnostic accuracy and reproducibility.
Kim HS; Goh MJ; Kim N; Choi CG; Kim SJ; Kim JH
Radiology; 2014 Dec; 273(3):831-43. PubMed ID: 24885857
[TBL] [Abstract][Full Text] [Related]
13. Diffusion tensor imaging in glioblastoma multiforme and brain metastases: the role of p, q, L, and fractional anisotropy.
Wang W; Steward CE; Desmond PM
AJNR Am J Neuroradiol; 2009 Jan; 30(1):203-8. PubMed ID: 18842762
[TBL] [Abstract][Full Text] [Related]
14. Quantitative Evaluation of Diffusion and Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Differentiation Between Primary Central Nervous System Lymphoma and Glioblastoma.
Lu S; Wang S; Gao Q; Zhou M; Li Y; Cao P; Hong X; Shi H
J Comput Assist Tomogr; 2017; 41(6):898-903. PubMed ID: 28806317
[TBL] [Abstract][Full Text] [Related]
15. Multiparametric imaging-based differentiation of lymphoma and glioblastoma: using T1-perfusion, diffusion, and susceptibility-weighted MRI.
Saini J; Kumar Gupta P; Awasthi A; Pandey CM; Singh A; Patir R; Ahlawat S; Sadashiva N; Mahadevan A; Kumar Gupta R
Clin Radiol; 2018 Nov; 73(11):986.e7-986.e15. PubMed ID: 30197047
[TBL] [Abstract][Full Text] [Related]
16. Differentiating Glioblastomas from Solitary Brain Metastases Using Arterial Spin Labeling Perfusion- and Diffusion Tensor Imaging-Derived Metrics.
Abdel Razek AAK; Talaat M; El-Serougy L; Abdelsalam M; Gaballa G
World Neurosurg; 2019 Jul; 127():e593-e598. PubMed ID: 30928596
[TBL] [Abstract][Full Text] [Related]
17. Prediction of methylguanine methyltransferase promoter methylation in glioblastoma using dynamic contrast-enhanced magnetic resonance and diffusion tensor imaging.
Ahn SS; Shin NY; Chang JH; Kim SH; Kim EH; Kim DW; Lee SK
J Neurosurg; 2014 Aug; 121(2):367-73. PubMed ID: 24949678
[TBL] [Abstract][Full Text] [Related]
18. Uninterpretable Dynamic Susceptibility Contrast-Enhanced Perfusion MR Images in Patients with Post-Treatment Glioblastomas: Cross-Validation of Alternative Imaging Options.
Heo YJ; Kim HS; Park JE; Choi CG; Kim SJ
PLoS One; 2015; 10(8):e0136380. PubMed ID: 26296086
[TBL] [Abstract][Full Text] [Related]
19. Primary cerebral lymphoma and glioblastoma multiforme: differences in diffusion characteristics evaluated with diffusion tensor imaging.
Toh CH; Castillo M; Wong AM; Wei KC; Wong HF; Ng SH; Wan YL
AJNR Am J Neuroradiol; 2008 Mar; 29(3):471-5. PubMed ID: 18065516
[TBL] [Abstract][Full Text] [Related]
20. Distinguishing Tumor Recurrence From Radiation Necrosis in Treated Glioblastoma Using Multiparametric MRI.
Feng A; Yuan P; Huang T; Li L; Lyu J
Acad Radiol; 2022 Sep; 29(9):1320-1331. PubMed ID: 34896001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
